2ZHANEL GG,HOMENUIK K,NICHOL K,et al.The glycylcyclines:a comparative review with the tetracyclines[J].Drugs,2004,64(1):63-88.
3FRITSCHE T,SADER H,JONES R.Activity of tigecycline tested against an international collection(1999-2003)of resistant bacterial pathogens[J].Clin Microbiol Infect,2005,11(4):382.
4BRADFORD PA,WEAVER-SANDS DT,PETERSEN PJ,et al.In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-ahdominal infections[J].Clin Infect Dis,2005,41(Suppl 5):s315-S332.
5BOUCHER HW,WENNERSTEN CB,ELIOPOULOS GM.In vitro activities of the glycylcycline GAR-936 against grampositive bacteria[J].Antimicrob Agents Chemother,2000,44(8):2225-2229.
6BOUCHILLON SK,HOBAN DJ,JOHNSON BM,et al.In vitro evaluation of tigeeycline and comparative agents in 3049 clinical isolates 2001 to 2002[J].Diagn Microbiol Infect Dis,2005,51(4):291-295.
7MILATOVIC D,SCHMITZ FJ,VERHOEF J,et al.Activities of the glycylcycline tigecycline(GAR-936) against 1924 recent European clinical bacterial isolates[J].Antimicrob Agents Chemother,2003,47(1):400-404.
8EDLUND C,NORD CE.In-vitro susceptibility of anaerobic bacteria to GAR-936,a new glycylcycline[J].Clin Microbiol Infect,2000,6(3):158-163.
9BETRIU C,CULEBRAS E,GOMEZ M,et al.In vitro activity of tigecycline against Bacteroides species[J].J Antimicrob Chemother,2005,56(2):349-352.
10JACOBUS NV,MCDERMOTT LA,RUTHAZER R,et al.In vitro activities of tigecycline against the Bacteroides fragilis group[J].Antimicrob Agents Chemother,2004,48(3):1034-1036.
